Exhibit 31(b)

CERTIFICATIONS
______________
I, Edward J. Weisberger, certify that:

  1.    I  have  reviewed this quarterly report on Form  10Q-SB/A  of
  IGENE Biotechnology, Inc.;

  2.    Based  on  my  knowledge, this report does  not  contain  any
  untrue  statement  of a material fact or omit to state  a  material
  fact  necessary  to  make the statements  made,  in  light  of  the
  circumstances   under  which  such  statements   were   made,   not
  misleading with respect to the period covered by this report;

  3.    Based  on my knowledge, the financial statements,  and  other
  financial  information included in this report, fairly  present  in
  all   material  respects  the  financial  condition,   results   of
  operations and cash flows of the small business issuer as  of,  and
  for, the periods presented in this report;

  4.   The small business issuer's other certifying officer(s) and  I
  are   responsible  for  establishing  and  maintaining   disclosure
  controls  and  procedures (as defined in Exchange  Act  Rules  13a-
  15(e) and 15d-15(e)) for the small business issuer and have:

          (a)  Designed  such disclosure controls and procedures,  or
          caused  such  disclosure  controls  and  procedures  to  be
          designed  under  our supervision, to ensure  that  material
          information   relating  to  the  small   business   issuer,
          including its consolidated subsidiaries, is made  known  to
          us by others within those entities, particularly during the
          period in which this report is being prepared;

          (b)  Evaluated  the  effectiveness of  the  small  business
          issuer's  disclosure controls and procedures and  presented
          in  this report our conclusions about the effectiveness  of
          the  disclosure controls and procedures, as of the  end  of
          the period covered by this report based on such evaluation;
          and

          (c)  Disclosed  in  this report any  change  in  the  small
          business issuer's internal control over financial reporting
          that  occurred  during  the small  business  issuer's  most
          recent  fiscal quarter (the small business issuer's  fourth
          fiscal  quarter in the case of an annual report)  that  has
          materially  affected, or is reasonably likely to materially
          affect,  the small business issuer's internal control  over
          financial reporting; and

  5.   The small business issuer's other certifying officer(s) and  I
  have  disclosed,  based on our most recent evaluation  of  internal
  control  over  financial reporting, to the small business  issuer's
  auditors  and  the  audit committee of the small business  issuer's
  board   of   directors  (or  persons  performing   the   equivalent
  functions):

          (a) All significant deficiencies and material weaknesses in
          the  design or operation of internal control over financial
          reporting  which are reasonably likely to adversely  affect
          the  small  business issuer's ability to  record,  process,
          summarize and report financial information; and

          (b)  Any  fraud,  whether  or not material,  that  involves
          management  or other employees who have a significant  role
          in  the  small  business  issuer's  internal  control  over
          financial reporting.

Date: September 28, 2005

/s/EDWARD J. WEISBERGER
_____________________________
   EDWARD J. WEISBERGER
   Chief Financial Officer